Listed Company Ir Executive Reported to Prosecutors for Received 500 Million Won Using Undisclosed Information on ‘Immunotherapy Approval’
2 Articles
2 Articles
Listed Company IR Executive Reported to Prosecutors for Pouring 500 Million Won from Undisclosed Information on Immunotherapy Approval. An executive of a listed company has been reported to the prosecution for pocketing illicit profits in the 500 million won range by trading stocks after knowing in advance about the approval of an immunotherapy drug. At its 6th regular meeting on the 25th, the Securities and Futures Commission of the Financial S…
[Digital Daily Reporter Kim Nam-gyu] An IR executive, who is the first to receive inside information from a listed company, has been reported to the prosecution on charges of obtaining illicit profits in the range of 500 million won by using non-public information. The Securities and Futures Commission announced on the 25th, following a regular meeting, that it has reported former executive C of a KOSDAQ-listed company to the prosecution on cha…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
